Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants

Clinical trial NCT06912295 · RECRUITING

Trial details

NCT number: NCT06912295
Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-03-21
Primary completion: 2025-08-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.